Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology
Synchron has secured $200 million in a Series D funding round to accelerate the commercialization of its Stentrode™ brain-computer interface (BCI) platform. This investment will support the expansion of AI and engineering operations in New York and San Diego.
About the Stentrode™ Platform
The Stentrode™ is an endovascular electrode array designed to enable brain-computer communication without the need for open brain surgery.
Photo caption: The Stentrode™ Endovascular Electrode Array
Photo credit: Synchron
Media Contact
Kimberly Ha, [email protected]
Author's summary: Synchron's $200 million funding will boost the development and market introduction of its innovative Stentrode™ brain-computer interface, enhancing AI and engineering efforts across key US cities.